MBBS, MD, DM (Gastroenterology) with over 20 years of experience in Medical Gastroenterology and 4 years of DM postgraduate teaching experience. Actively involved in clinical trials and studies in GERD, NAFLD, HCV, peptic ulcer disease, and IBD, including Vedolizumab studies.

Inflammatory Bowel Disease (IBD) remains a significant clinical challenge, requiring effective long-term management strategies. This session on “Real World Experience of Vedolizumab – Indian Phase 4 Data” will highlight practical insights from Indian clinical experience, focusing on treatment outcomes, safety, and real-world applicability of Vedolizumab in IBD management. Led by Dr. A Kavitha, the discussion is designed for IBD specialists, gastroenterologists, and general medicine practitioners.

Dr. A Kavitha

1

-

-

-

Upcoming Sessions